Sec24 Inhibitors

Sec24 Inhibitors predominantly act on the secretory pathway, which governs the movement of proteins from the ER to the Golgi and beyond. Sec24, as a COPII component, plays a crucial role in this pathway. The agents listed above can impact various stages or components of this process, thus indirectly affecting Sec24 function.

Brefeldin A is a well-known disruptor of ER-to-Golgi transport, exerting its influence by inhibiting ARF exchange factors, whereas Monensin acts as an ionophore that affects the functionality of the Golgi apparatus. Exo1 directly impairs COPII vesicle formation, which is central to Sec24's role. The influence of H89, a PKA inhibitor, Wortmannin, a PI3K inhibitor, and Tyrphostin AG1478, an EGFR kinase inhibitor, on vesicle transport demonstrates the complexity and interconnected nature of cellular signaling pathways and vesicular transport mechanisms. Several of the inhibitors target cytoskeletal components, which are fundamental for vesicle movement. Nocodazole and Colchicine both act on microtubules, disrupting their assembly, while Latrunculin A targets actin filaments. Disruption of the cytoskeleton can hinder the vesicle transport process, thereby indirectly affecting the context in which Sec24 functions. Similarly, Dynasore, which inhibits dynamin, can influence vesicle scission, a process that occurs post-COPII vesicle formation.